A pentadecapeptide first found in gastric juice — one of the most-studied compounds in tissue-repair research, across tendon, ligament, and gut models.
The research form of thymosin β-4, a 43-amino-acid peptide found in nearly every cell. The classic partner to BPC-157 — studied for wound healing, blood-vessel formation, and tissue remodeling.
The active C-terminal fragment of α-MSH, researched for its anti-inflammatory signaling across the gut, skin, and immune system.
A repair-oriented blend pairing tissue-repair, anti-inflammatory, and skin peptides — each studied for complementary roles in recovery and regeneration.
A recovery-and-skin blend that combines a collagen-supporting peptide with two of the most-researched tissue-repair compounds.
A copper-binding tripeptide and a mainstay of advanced skincare, researched for its role in collagen synthesis, skin firmness, and tissue regeneration.
A GHRH analog that signals the pituitary to release the body's own growth hormone — a long-standing tool in growth-hormone and recovery research.
A two-peptide pairing — a GHRH analog plus a selective secretagogue — studied together to prompt a fuller, more natural release of the body's own growth hormone.
A stabilized, FDA-approved GHRH analog, recognized in clinical use for reducing visceral (deep abdominal) fat, with ongoing interest in metabolic health.
The peptides behind Ozempic, Wegovy, and Mounjaro, engineered to mimic the gut hormone GLP-1 — the most clinically validated peptides for glycemic control and weight, backed by large randomized trials.
An investigational "triple agonist" acting on the GLP-1, GIP, and glucagon receptors at once — reported in late-stage trials with some of the largest weight-reduction figures yet seen in the class.
A peptide encoded within mitochondrial DNA. A focus of metabolic research as an "exercise-mimetic" signal tied to energy use and insulin sensitivity.
A coenzyme central to cellular energy and DNA repair. Its decline with age — and the precursors that restore it (NMN, NR) — anchor modern longevity research.
A four-amino-acid peptide from Russian gerontology, proposed to activate telomerase — the enzyme that maintains the protective caps on our chromosomes. A long-standing focus of longevity research.
Also known as elamipretide, a peptide that targets cardiolipin in the mitochondrial membrane — studied in mitochondrial medicine and FDA-approved for a rare genetic disease.
A peptide derived from ACTH, developed in Russia and used there in neurology — studied for focus, memory, and neuroprotection via BDNF.
A peptide based on the immune fragment tuftsin, developed in Russia as an anxiolytic — researched for calm, mood, and stress resilience.
A melanocortin peptide that works through the nervous system rather than blood flow. FDA-approved as Vyleesi, and researched for desire and arousal.